Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/2/2026

Guidelines for Minimizing Burning and Tissue Damage from Peptide Injections

Temperature Management

  • Allow peptide to warm to room temperature (approximately 15‑30 °C) by removing it from refrigeration 30–60 minutes before injection; injecting cold peptide is a primary cause of injection pain and can contribute to tissue complications such as lipodystrophy. 1
  • Store opened peptide vials or pens at ambient temperature away from direct sunlight to maintain appropriate temperature stability. 1

Injection Site Preparation

  • Disinfect the skin with an alcohol swab and allow the alcohol to evaporate completely before injecting; do not wipe the area or inject while the skin is still wet. 1
  • Choose injection sites that contain sufficient subcutaneous fat (e.g., abdomen, thighs, buttocks, upper arms). [1][2]
  • Verify that the skin is clean and intact prior to injection. 2

Systematic Site Rotation

  • Rotate injection sites at least 1 cm (≈ one adult finger width) apart in a consistent direction to reduce tissue sensitization. [1][2]
  • Divide each injection zone into quadrants or halves and use a different quadrant/half each week to ensure regular zone change. [1][2]
  • Never inject into areas of lipodystrophy, scars, stretch marks, tattoos, or any site showing edema, infection, inflammation, or ulceration. [1][2]
  • Avoid injecting through clothing, as this interferes with proper technique. 2

Injection Technique & Common Pitfalls

  • Do not inject immediately after removing peptide from refrigeration; this is the most common cause of burning sensations. 1
  • Avoid reusing the same injection site too frequently; repeated trauma increases pain sensitivity. [1][2]
  • Ensure that alcohol has fully evaporated from the skin surface before injection; injecting while alcohol is present can exacerbate burning. [1][2]
  • Use a proper sub‑cutaneous injection angle (typically 90 °) with an appropriate needle length to prevent inadvertent intramuscular delivery and rare complications such as compartment syndrome. 1